(b)TMB	(blood) tumor mutational burden
NFE2L2	nuclear factor erythroid-2-related factor-2
ARID1A	AT-rich interacting domain-containing protein 1A gene
ARID1B	AT-rich interacting domain-containing protein 1B gene
BC	breast cancer
BEAMing	beads, emulsions, amplification and magnetics
CDRs	complementarity-determining regions
cf tumor DNA	circulating cell-free tumor DNA
cfDNA	circulating cell-free DNA
CGP	comprehensive genomic profiling
CI	confidence interval
CRC	colorectal cancer
CTCs	circulating tumor cells
CX3CR1	CX3C chemokine receptor 1
CYTIP	Cytohesin 1 Interacting Protein
ddPCR	digital droplet PCR
eDMRs	differentially methylated regions overlapping enhancers
EGFR	epidermal growth factor receptor
eNose	electronic nose
EpCAM	epithelial cell adhesion molecule
EVs	extracellular vesicles
FDA	food and drug administration
FMTs	fecal microbiota transplantations
FOXP1	forkhead box P1
gDNA	genomic DNA
H&NC	head and neck cancer
HR	hazard ratio
ISET	Isolation by SizE of Tumor cells
KEAP1	kelch-like ECH-associated protein 1
KRAS	Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
Mb	mega base
miRNA	microRNA
MSC	miRNA signature classifier
NGS	next-generation sequencing
NSCLC	non-small cell lung cancer
ORR	overall response rate
OS	overall survival
PBMC	peripheral blood mononuclear cell
PD	progressive disease
PD-1	programmed cell death protein 1
PD-L1	programmed cell death ligand 1
pDMRs	differentially methylated regions overlapping promoters
PFS	progression-free survival
PTEN	phosphatase and TENsin homolog
PTGER4	prostaglandin E receptor 4
RCC	renal cell carcinoma
RECIST	response evaluation criteria in solid tumors
RT-PCR	real time-PCR
SEPT9	septin 9
SHOX2	short stature homeobox 2
STK11	serine/threonine kinase 11
TCR	T cell receptor
TEX	tumor-derived exosomes
tTMB	tissue tumor mutational burden
TNFSF8	TNF superfamily member 8
UC	urotherial carcininoma
VOCs	volatile organic compounds
WES	whole exome sequencing